Immunotherapy of Cancer Using Donor Lymphocytes Labelled With In-vitro Bispecific Antibodies.
Clinical trial NCT00149019 · WITHDRAWN
Trial details
- NCT number
- NCT00149019
- Sponsor
- Hadassah Medical Organization
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-05-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.